| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells | [1]Manon Lernoux, [2]Michael Schnekenburger, [3]Hélène Losson, [4]Koen Vermeulen, [5]Hyunggu Hahn, [6]Déborah Gérard, [7]Jin-Young Lee, [8]Aloran Mazumder, [9]Muneer Ahamed, [10]Christo Christov, [11]Dong-Wook Kim, [12]Mario Dicato, [13]Guy Bormans, [14]Byung Woo Han, [15]Marc Diederich [Full author list] | Clinical Epigenetics [missing] | DOI: 10.1186/S13148-020-00839-Z [ORCID]
PubMed: 32430012 [ORCID]
| imatinib [missing]; chronic myeloid leukemia [missing] | 2020-05-19 | Aloran Mazumder (Q117240162; 4 items)
|
| Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells | [1]Cindy Grandjenette, [2]Michael Schnekenburger, [3]Anthoula Gaigneaux, [4]Déborah Gérard, [5]Christo Christov, [6]Aloran Mazumder, [7]Mario Dicato, [8]Marc Diederich [Full author list] | Cancer Letters [missing] | DOI: 10.1016/J.CANLET.2019.11.017 [ORCID]
PubMed: 31734352 [ORCID]
| imatinib [missing]; chronic myeloid leukemia [missing] | 2019-11-14 | Aloran Mazumder (Q117240162; 4 items)
|
| Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release | [1]Aloran Mazumder, [2]Jin-Young Lee, [3]Oualid Talhi, [4]Claudia Cerella, [5]Sébastien Chateauvieux, [6]Anthoula Gaigneaux, [7]Che Ry Hong, [8]Hyoung Jin Kang, [9]Youngjo Lee, [10]Kyu-Won Kim, [11]Dong-Wook Kim, [12]Hee-Young Shin, [13]Mario Dicato, [14]Khaldoun Bachari, [15]Artur M S Silva, [16]Barbora Orlikova-Boyer, [17]Marc Diederich [Full author list] | Cancer Letters [missing] | DOI: 10.1016/J.CANLET.2018.07.041 [ORCID]
PubMed: 30205168 [ORCID]
| imatinib [missing] | 2018-09-08 | Aloran Mazumder (Q117240162; 4 items)
|
| Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts | [1]Jin-Young Lee, [2]Aloran Mazumder, [3]Marc Diederich [Full author list] | Journal of Visualized Experiments [missing] | DOI: 10.3791/57490 [ORCID]
PubMed: 30010672 [ORCID]
| | 2018-06-26 | Aloran Mazumder (Q117240162; 4 items)
|
| Natural scaffolds in anticancer therapy and precision medicine | [1]Aloran Mazumder, [2]Claudia Cerella, [3]Marc Diederich [Full author list] | Biotechnology Advances [missing] | DOI: 10.1016/J.BIOTECHADV.2018.04.009 [ORCID]
PubMed: 29729870 [ORCID]
| | 2018-05-03 | Aloran Mazumder (Q117240162; 4 items)
|
| Cardiac Glycoside Glucoevatromonoside Induces Cancer Type-Specific Cell Death | [1]Naira F Z Schneider, [2]Claudia Cerella, [3]Jin-Young Lee, [4]Aloran Mazumder, [5]Kyung Rok Kim, [6]Annelise de Carvalho, [7]Jennifer Munkert, [8]Rodrigo M Pádua, [9]Wolfgang Kreis, [10]Kyu-Won Kim, [11]Christo Christov, [12]Mario Dicato, [13]Hyun-Jung Kim, [14]Byung Woo Han, [15]Fernão Castro Braga, [16]Cláudia M O Simões, [17]Marc Diederich [Full author list] | Frontiers in Pharmacology [missing] | DOI: 10.3389/FPHAR.2018.00070 [ORCID]
PubMed: 29545747 [ORCID]
| | 2018-03-01 | Aloran Mazumder (Q117240162; 4 items)
|
| Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines | [1]Michael Schnekenburger, [2]Eric Goffin, [3]Jin-Young Lee, [4]Jun Young Jang, [5]Aloran Mazumder, [6]Seungwon Ji, [7]Bernard Rogister, [8]Nafila Bouider, [9]Florence Lefranc, [10]Walter Miklos, [11]Véronique Mathieu, [12]Pascal de Tullio, [13]Kyu-Won Kim, [14]Mario Dicato, [15]Walter Berger, [16]Byung Woo Han, [17]Robert Kiss, [18]Bernard Pirotte, [19]Marc Diederich [Full author list] | Journal of Medicinal Chemistry [missing] | DOI: 10.1021/ACS.JMEDCHEM.7B00533 [ORCID]
PubMed: 28475330 [ORCID]
| | 2017-05-25 | Aloran Mazumder (Q117240162; 4 items)
|
| Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells | [1]Cristina Florean, [2]Michael Schnekenburger, [3]Jin-Young Lee, [4]Kyung Rok Kim, [5]Aloran Mazumder, [6]Sungmi Song, [7]Jae-Myun Kim, [8]Cindy Grandjenette, [9]Jeoung-Gyun Kim, [10]Ah-Young Yoon, [11]Mario Dicato, [12]Kyu-Won Kim, [13]Christo Christov, [14]Byung Woo Han, [15]Peter Proksch, [16]Marc Diederich [Full author list] | Oncotarget [missing] | DOI: 10.18632/ONCOTARGET.8210 [ORCID]
PubMed: 27006469 [ORCID]
| | 2016-03-19 | Aloran Mazumder (Q117240162; 4 items)
|
| 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer | [1]Carole Seidel, [2]Michael Schnekenburger, [3]Aloran Mazumder, [4]Marie-Hélène Teiten, [5]Gilbert Kirsch, [6]Mario Dicato, [7]Marc Diederich [Full author list] | Biochemical Pharmacology [missing] | DOI: 10.1016/J.BCP.2015.11.005 [ORCID]
PubMed: 26549368 [ORCID]
| molecular chaperones [missing] | 2015-11-05 | Aloran Mazumder (Q117240162; 4 items)
|